Air Liquide has today (23rd Oct) released its third quarter (Q3) results reporting a “marked recovery” in sales across all regions and all business lines.
The French industrial gas group said highlights from Q3 included the mobilisation of its healthcare teams around the world in the fight against Covid-19, particularly to supply medical oxygen; the finalisation of its agreement with Sasol to acquire the biggest oxygen production site in the world; and its more than $160m investment to build a new ASU and partial oxidation unit in the US.
“This third quarter saw a marked recovery in sales. Compared with the 2nd quarter of 2020, which was impacted by the pandemic, all business lines and all regions improved,” Benoît Potier, Chairman and CEO of the Air Liquide Group, commented.
Group revenue for Q3 totalled €5bn. Air Liquide said its business model has proven its resilience in recent months in a challenging public health context.
... to continue reading you must be subscribed
